(a) The Board of Trustees of the Minnesota State Colleges and Universities must, and the Board of Regents of the University of Minnesota is requested to:
- (1) maintain a supply of opiate antagonists, as defined in section 604A.04, subdivision 1, at each campus site to be administered in compliance with section 151.37, subdivision 12; and
- (2) have at least two doses of a nasal opiate antagonist available on site at each campus residential building.